Aspirin-induced respiratory disease is a progressive condition that affects the airways when someone is sensitive to aspirin or similar pain relievers. It often includes nasal polyps, chronic sinus problems, and asthma-like breathing trouble. Symptoms can flare within hours of taking aspirin or other NSAIDs and tend to be long term. Adults are most often affected, and not everyone will have the same experience. Treatment focuses on avoiding trigger medicines, daily inhalers and nasal therapies, sinus surgery when needed, and sometimes aspirin desensitization under specialist care; most people live normal lifespans with good management.
Overview
Aspirin-induced respiratory diseaseSymptoms
Early symptoms of aspirin-induced respiratory disease include ongoing nose and sinus trouble, often with nasal polyps and reduced smell, plus asthma-like breathing problems. Symptoms flare after aspirin or many NSAIDs: wheeze, chest tightness, cough, and a stuffy or runny nose.
Outlook and prognosis
Most people with Aspirin-induced respiratory disease do well with careful trigger avoidance, daily asthma and sinus control, and guidance from a specialist. Symptoms often ease after desensitization therapy alongside ongoing aspirin under medical supervision. Long term, flare-ups can still happen, but hospitalizations become less common with a tailored plan.
Causes and risk factors
Aspirin-induced respiratory disease stems from a nonallergic reaction to aspirin and similar pain relievers, driving excess inflammatory chemicals. Risk rises in adults with asthma and nasal polyps, especially women; alcohol and tobacco smoke can worsen symptoms; genetics seem minor.
Genetic influences
Genetics play a meaningful role in Aspirin-induced respiratory disease, but it isn’t the whole story. Variations in immune and airway-related genes raise risk and shape severity, yet environmental triggers (like viral infections and allergens) strongly influence who develops it and when.
Diagnosis
Diagnosis of Aspirin-induced respiratory disease relies on history: asthma, nasal polyps, and breathing symptoms after aspirin or other NSAIDs. A supervised aspirin challenge can confirm it. Breathing tests and sinus imaging help gauge severity and exclude similar conditions.
Treatment and drugs
Treatment for aspirin-induced respiratory disease focuses on controlling asthma and sinus symptoms, reducing nasal polyps, and preventing reactions. Care often includes inhaled asthma medicines, nasal steroid sprays or rinses, biologic therapies, and careful avoidance of trigger pain relievers. Some people benefit from supervised aspirin desensitization followed by daily aspirin.
Symptoms
Aspirin-induced respiratory disease can affect daily breathing and the nose in ways that feel like stubborn asthma and sinus trouble. Early symptoms of aspirin-induced respiratory disease often include a stuffy, runny nose, reduced sense of smell, and asthma that flares. Symptoms vary from person to person and can change over time. Many people notice symptoms surge after aspirin or other pain relievers, and sometimes after alcohol.
Wheezing, chest tightness, coughing, and shortness of breath often come on or get worse without much warning. Triggers include exercise, colds, smoke, or strong smells. If breathing suddenly worsens after a pain reliever, seek urgent care.
Ongoing nasal blockage with a watery or thick drip is common and can feel like year-round allergies. Postnasal drip may lead to throat clearing or a nighttime cough. Over-the-counter sprays may give brief relief but symptoms tend to return.
Smell and taste often fade gradually, sometimes disappearing during flares. This is often linked to swollen tissue and nasal polyps. You might notice foods taste bland or coffee seems weaker.
Aching in the cheeks, around the eyes, or forehead can build with headaches. Repeated sinus infections are frequent and may need antibiotics or steroid sprays. Symptoms sometimes linger even between colds.
How people usually first notice Aspirin-induced respiratory disease?
Many people first notice aspirin-induced respiratory disease after taking aspirin or another NSAID and then developing sudden nasal congestion, a tight chest, wheezing, or shortness of breath within minutes to a few hours. For many, there’s already a background of adult-onset asthma and chronic sinus trouble with nasal polyps, so the reaction feels like a sharp worsening of symptoms they’ve been managing. These first signs of aspirin-induced respiratory disease often lead to urgent care visits after an unexpected reaction to a common pain reliever.
Types of Aspirin-induced respiratory disease
Aspirin-induced respiratory disease affects breathing and sinus health after exposure to aspirin or similar pain relievers. Clinicians often describe them in these categories: symptoms in the nose and sinuses, asthma-type breathing symptoms, and reactions triggered by aspirin and related drugs. Early symptoms of Aspirin-induced respiratory disease often involve the nose, then the chest, and may shift over time.
Nasal and sinus
Ongoing stuffiness, reduced smell, and thick drainage are common. Many have nasal polyps that block airflow and keep infections coming back. Some types show up in daily routines—like eating, sleeping, or energy levels.
Asthma features
Wheeze, chest tightness, and shortness of breath flare and settle but can become persistent. Exercise, cold air, or allergens may make chest symptoms worse. Even within the same type, intensity can range from mild to severe.
Drug-triggered reactions
Symptoms begin within minutes to a few hours after aspirin or similar NSAIDs. People may notice sudden nasal burning, tearing, flushing, and then coughing or wheezing. Not everyone will experience every type.
What genetics can tell you about symptoms
Some people with aspirin‑induced respiratory disease have changes in genes that tune inflammation, like ALOX5, LTC4S, and HLA variants. These can boost leukotriene signals and immune reactivity, linking aspirin exposure to faster-onset wheezing, nasal congestion, sinus polyps, and asthma flares.
Causes and risk factors
Aspirin and many common pain relievers can trigger airway inflammation and nasal swelling in aspirin-induced respiratory disease. These medicines block one pathway and the body makes more inflammatory chemicals called leukotrienes that tighten the breathing tubes. Risk is higher if you have asthma, nasal polyps, or chronic sinus trouble, and a family history may raise susceptibility. Colds, tobacco smoke, strong odors, or alcohol can worsen reactions, and some notice early symptoms of aspirin-induced respiratory disease after a drink or a viral infection. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
With aspirin-induced respiratory disease (AERD), reactions tend to happen after exposure to certain pain relievers, and everyday irritants can make breathing symptoms more likely. That said, biology and environment work hand in hand. Below are key environmental and biological risk factors for aspirin-induced respiratory disease that can raise the chance or intensity of a reaction.
Exposure to aspirin, ibuprofen, naproxen, and similar pain relievers can spark nasal congestion, wheezing, or chest tightness in AERD. Even small amounts, including in some combined cold or flu medicines, may be enough. Reactions often begin within minutes to a few hours.
Tobacco smoke, strong odors, cleaning sprays, and traffic pollution can inflame the airways. This irritation can lower the threshold for a reaction after taking an NSAID. For some living with AERD, flares are stronger during heavy exposure days.
Developing asthma in adulthood is closely linked with aspirin-induced respiratory disease. People with adult-onset asthma are more likely to react to aspirin or similar drugs. The risk is higher when asthma control is unstable.
Long-standing sinus inflammation, especially with frequent congestion or infections, is a strong marker of AERD. Ongoing swelling in the nose and sinuses makes reactions to NSAIDs more likely and often more intense. Many also have nasal polyps alongside these sinus symptoms.
Genetic risk factors
Genetic influences in Aspirin-induced respiratory disease appear complex and mainly polygenic. No single gene causes it; small differences across several inflammation and lipid-signaling genes can add up to raise risk. Some risk factors are inherited through our genes. Research points to changes in leukotriene and prostaglandin pathways and in HLA immune genes, and these genetic risk factors for Aspirin-induced respiratory disease may vary by ancestry.
Family history: Having a close relative with Aspirin-induced respiratory disease, asthma with nasal polyps, or strong reactions to aspirin or other NSAIDs suggests a higher inherited risk. Families show clustering, but this condition does not follow a single-gene pattern.
Polygenic susceptibility: Many small DNA differences can add up to change how airways control inflammation. Each one has a modest effect, but together they can raise the chance of the condition.
HLA region variants: Changes near immune-system genes in the HLA region may shape how the body reacts to aspirin-like drugs. Certain versions, such as HLA-DPB1*03 in some groups, have been linked to increased risk, though results vary by ancestry.
Leukotriene enzymes: Variants in genes that make leukotrienes, such as ALOX5 and LTC4S, can tilt the balance toward overproduction of these airway signals. This can set the stage for the reactions seen in Aspirin-induced respiratory disease.
Leukotriene receptors: Differences in CYSLTR1 and CYSLTR2 may heighten the airway’s sensitivity to leukotrienes. This can intensify wheeze or nasal symptoms when exposed to aspirin or similar medicines.
Prostaglandin pathway: Variants in PTGES or the prostaglandin E2 receptors (PTGER2 and PTGER3) may reduce a natural braking signal in the airways. With less of this signal, aspirin exposure can more easily tip inflammation toward leukotrienes.
Type 2 immunity: Common changes in IL4, IL5, IL13, TSLP, or IL33 can favor eosinophil-driven inflammation and nasal polyp growth. This immune background may raise the chance of Aspirin-induced respiratory disease in people who are already predisposed.
Ancestry-specific effects: The impact of risk variants is not the same in all populations. Some links appear strong in European or East Asian groups but are weaker or absent elsewhere.
Rare variant reports: Small studies have described uncommon changes in additional genes involved in arachidonic-acid and mast-cell pathways. These seem to apply to only a minority of people with Aspirin-induced respiratory disease, and larger studies are needed to confirm their role.
Lifestyle risk factors
Certain day-to-day choices can worsen symptom flares and disease control in Aspirin-induced respiratory disease. The main lifestyle risk factors for Aspirin-induced respiratory disease relate to medications taken, alcohol use, diet patterns, weight and activity, and habits that aggravate airway inflammation. Adjusting these behaviors may reduce reactions and improve breathing control.
Taking aspirin or other COX-1 NSAIDs can trigger sudden nasal congestion, wheeze, and asthma attacks in AERD. Avoidance or physician-guided desensitization is key to prevent exacerbations.
Even small amounts of alcohol frequently provoke nasal blockage, wheeze, or chest tightness in AERD. Limiting or avoiding alcohol can reduce flare frequency.
For some people with AERD, foods and drinks high in salicylates can intensify nasal and asthma symptoms. A supervised trial of a lower-salicylate diet may help identify personal triggers.
Diets high in omega-6 fats and low in omega-3s may favor leukotriene-driven inflammation in AERD. Shifting toward more omega-3–rich foods (e.g., fish) may modestly ease respiratory symptoms.
Risk prevention
If you live with aspirin‑induced respiratory disease (AERD), the most effective prevention is avoiding medicines that set off breathing and sinus flares. Prevention works best when combined with regular check-ups. Recognizing early symptoms of aspirin-induced respiratory disease can help you steer clear of triggers and act quickly. Other steps focus on safer pain relief, controlling airway inflammation, and planning ahead so surprises are less likely.
Steer clear of aspirin and most traditional NSAIDs, which commonly trigger AERD symptoms. Even small amounts can cause sudden nasal congestion, wheeze, or chest tightness.
Many cold and flu products, pain gels, and combination medicines contain aspirin or NSAIDs. Read ingredient lists and ask a pharmacist to help you find AERD‑safe options.
Acetaminophen at low doses is often tolerated, while higher doses can still trigger symptoms in some people with AERD. COX‑2–selective pain relievers may be options under specialist guidance; dosing and safety need medical input. Talk to your doctor about which preventive steps are right for you.
In a specialist clinic, carefully supervised aspirin desensitization can reduce reactions and improve sinus and asthma control. It requires taking daily aspirin afterward to maintain the effect and is not right for everyone.
Transmission
Aspirin-induced respiratory disease (AERD) is not contagious and cannot be transferred between people. If you’re wondering how Aspirin-induced respiratory disease is transmitted, it isn’t—reactions occur only when someone with AERD takes certain pain relievers like aspirin, ibuprofen, or naproxen. You can’t catch it from being near, touching, or sharing utensils with someone who has AERD. It also doesn’t follow a clear inheritance pattern, so there’s no predictable genetic transmission from parent to child.
When to test your genes
Consider genetic testing if you have severe, recurrent nasal polyps or asthma that worsens with aspirin/NSAIDs, especially with a strong family history of similar reactions. Testing can help rule out other inherited airway or inflammation disorders, guide medication choices, and inform desensitization planning. Discuss timing with an allergist or pulmonologist before aspirin challenges.
Diagnosis
Aspirin-induced respiratory disease often comes to light when asthma and sinus symptoms flare, then breathing suddenly worsens after taking aspirin or another common pain reliever. Doctors usually begin by asking about patterns—what happens, how quickly, and which medications trigger symptoms. Because there isn’t a single blood test for this condition, the diagnosis of Aspirin-induced respiratory disease is based on your history and, when needed, a carefully supervised aspirin challenge.
Clinicians look for the triad of asthma, chronic sinus symptoms with nasal polyps, and breathing reactions after aspirin or other NSAIDs. Noting timing, dose, and repeatability of reactions helps distinguish it from unrelated flares. A clear pattern strongly supports Aspirin-induced respiratory disease.
Your team reviews all pain relievers you’ve taken, including ibuprofen, naproxen, and cold remedies that may contain NSAIDs. Cross-reactions to several COX-1 painkillers point toward Aspirin-induced respiratory disease. Tolerance to COX-2–selective options can be a helpful clue but does not confirm the diagnosis.
Simple breathing tests measure airflow before and after a bronchodilator to assess asthma control. Results can show variable airway narrowing typical in people with Aspirin-induced respiratory disease. These tests also set a safe baseline before any aspirin challenge.
An ENT exam or nasal endoscopy looks for polyps and swollen tissue that fit the condition. A sinus CT scan can show the extent of sinus inflammation and polyps. These clinical features support the overall picture of Aspirin-induced respiratory disease.
Stages of Aspirin-induced respiratory disease
Aspirin-induced respiratory disease does not have defined progression stages. Symptoms can ebb and flow, often flaring with aspirin or other non-steroidal pain relievers rather than moving through fixed steps; early symptoms of aspirin-induced respiratory disease can include ongoing nasal congestion, a reduced sense of smell, and frequent sinus infections. Diagnosis is usually based on the pattern of nasal polyps and asthma together with breathing symptoms after aspirin or similar medicines, sometimes confirmed with a medically supervised aspirin challenge and breathing tests. Early and accurate diagnosis helps you plan ahead with confidence.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after being told they have aspirin-induced respiratory disease (AERD). For many living with AERD, day-to-day life improves once triggers are identified and a clear plan is in place. People often start to notice fewer sinus flares and more stable breathing after consistent use of inhalers or nasal therapies, treatment of nasal polyps, and careful avoidance of aspirin and similar pain relievers unless desensitization is done under medical supervision.
The outlook is not the same for everyone, but most people with AERD can expect a chronic, relapsing course that’s manageable with ongoing care. Prognosis refers to how a condition tends to change or stabilize over time. Without treatment, AERD can lead to frequent asthma attacks, repeated sinus infections, and loss of smell; with treatment, many regain smell at least partly and reduce urgent visits. Early symptoms of aspirin-induced respiratory disease—like sudden nasal congestion, wheeze, or chest tightness after taking an NSAID—often settle when those medicines are avoided and asthma and sinus care are optimized.
Serious complications are uncommon when AERD is recognized and treated, and AERD by itself is not considered a life-shortening condition. Mortality is rare and usually linked to severe, uncontrolled asthma or accidental exposure to aspirin/NSAIDs in someone with poorly controlled disease. Biologic medicines, sinus surgery when needed, and aspirin desensitization can further reduce flare-ups and improve quality of life in select people. Talk with your doctor about what your personal outlook might look like, including whether desensitization or a biologic is a good fit and how to handle pain relief safely going forward.
Long-term effects
For many, Aspirin-induced respiratory disease affects both breathing and day-to-day comfort over years, not just during flare-ups. It often follows a chronic path with ups and downs, especially around the nose, sinuses, and lungs. Long-term effects vary widely, and even persistent symptoms can loosen their grip with the right plan. People sometimes wonder about early symptoms of Aspirin-induced respiratory disease, but the long-term picture usually centers on repeat nasal issues and asthma control.
Soft growths in the nose tend to come back even after they shrink or are removed. This can lead to blockage, congestion, and a “stuffy” voice over the years.
Ongoing inflammation in the sinuses can cause pressure, facial pain, and thick drainage. Many living with Aspirin-induced respiratory disease notice these symptoms return in cycles.
Loss or blunting of smell is common and may wax and wane. For some, it becomes long-lasting and can dull the sense of taste as well.
Wheeze, cough, and chest tightness can persist beyond bad days and become more frequent. Over time, a few people develop more fixed breathing limits that don’t fully bounce back between flares.
How is it to live with Aspirin-induced respiratory disease?
Living with aspirin‑induced respiratory disease often means staying alert to hidden triggers while managing asthma- and sinus‑related symptoms. Daily life can involve reading labels carefully, avoiding certain pain relievers and cold remedies, using prescribed inhalers or nasal treatments, and planning around flare‑ups that can follow even small exposures. Many find that clear communication with family, friends, schools, and workplaces helps others understand why certain medicines and some environments aren’t safe, reducing accidental triggers and stress. With a consistent treatment plan and support from people around you, most can keep active routines and protect breathing day to day.
Treatment and drugs
Aspirin-induced respiratory disease is treated by avoiding aspirin and similar pain relievers that trigger symptoms, then controlling airway inflammation with daily medicines. Doctors often use inhaled corticosteroids with or without long-acting bronchodilators for asthma control, plus nasal steroid sprays or rinses for sinus and polyp symptoms. If symptoms remain frequent, options can include leukotriene blockers, short bursts of oral steroids during flares, or biologic injections that target specific inflammation pathways. Some centers offer aspirin desensitization, a supervised procedure that lets people take daily aspirin afterward to reduce nasal polyps and asthma attacks. Your doctor can help weigh the pros and cons of each option.
Non-drug treatment
Non-drug care for aspirin-induced respiratory disease focuses on avoiding triggers, supporting clear breathing, and making your home and routine friendlier to your airways. These steps work alongside your medical treatments to reduce flare-ups and improve day-to-day comfort. Alongside medicines, non-drug therapies can make symptoms less frequent and easier to manage. Your care team can help tailor these choices to your specific mix of asthma, sinus symptoms, and sensitivity to pain relievers.
Learn which medicines contain aspirin or other NSAIDs, including some cold and flu products. Read labels carefully and consider a medical ID alert to prevent accidental exposure.
Many people with aspirin-induced respiratory disease notice nasal congestion or wheeze after alcohol, even small amounts. Limiting or avoiding alcohol can prevent sudden symptoms.
A daily saltwater rinse can wash out mucus and irritants, ease congestion, and support sinus health. Isotonic or slightly hypertonic solutions are both options many find comfortable.
Endoscopic sinus surgery can remove polyps and open blocked passages when symptoms persist despite other care. It is not a cure, but it can improve breathing and reduce pressure.
Your genes may have an impact on how drugs work for you
Some people with aspirin‑induced respiratory disease process anti‑inflammatory and asthma medicines differently because of inherited differences in drug‑handling enzymes and inflammation pathways. These genetic patterns can affect benefit and side‑effects, so clinicians may tailor doses or choose alternatives.
Pharmacological treatments
Treatment for aspirin-induced respiratory disease (AERD) usually combines standard asthma and sinus medicines with options tailored to reduce reactions to aspirin and related drugs. Not everyone responds to the same medication in the same way. During flares or when early symptoms of aspirin-induced respiratory disease are ramping up, fast-relief inhalers and anti-inflammatory medicines can help stabilize breathing. Your care team may layer treatments and adjust them over time to control airway swelling, prevent nasal polyps from coming back, and reduce asthma attacks.
Fluticasone, budesonide, or beclomethasone calm airway swelling to prevent wheeze and chest tightness. They are often everyday controller medicines for AERD.
Fluticasone or mometasone nasal sprays reduce congestion and help slow polyp regrowth. Using them consistently can ease pressure and improve smell over time.
Montelukast or zafirlukast can blunt leukotriene signals that are often high in AERD. They may reduce chest symptoms and sinus pressure; watch for mood or sleep changes with montelukast.
Zileuton lowers leukotriene production at its source and can help when symptoms persist. Liver tests are checked regularly, and it may interact with some other medicines.
Genetic influences
Research suggests some people are biologically more prone to aspirin-induced respiratory disease because of how their bodies regulate inflammatory chemicals involved in breathing and sinus tissue. Genetics is only one piece of the puzzle, but certain inherited differences in the pathways that make inflammatory messengers like leukotrienes and prostaglandins can tilt this balance toward extra sensitivity to aspirin and similar pain relievers. Studies have linked variations in several immune and inflammation genes to a higher chance of developing the condition, yet no single “AERD gene” has been confirmed, and findings can differ by ancestry. Because of this, aspirin-induced respiratory disease usually does not follow a clear inheritance pattern; it may show up in a family here and there, but many living with it have no close relatives with the same condition. There is currently no routine genetic test to predict who will develop AERD, and genetic results cannot determine how severe symptoms will be. If you’re concerned about genetic risk for aspirin-induced respiratory disease, sharing your personal and family history of asthma, nasal polyps, and medication reactions can help your clinician gauge risk and discuss prevention and treatment options.
Is Aspirin-induced respiratory disease genetic?
Genetics play a meaningful role in Aspirin-induced respiratory disease, but it isn’t the whole story. Variations in immune and airway-related genes raise risk and shape severity, yet environmental triggers (like viral infections and allergens) strongly influence who develops it and when.
Pharmacogenetics—how genetics influence drug effects
Treatment choices and responses in aspirin-induced respiratory disease vary widely from person to person. Genetics won’t change the early symptoms of Aspirin-induced respiratory disease, but they may help explain why some treatments work better than others. Studies suggest that differences in genes that regulate inflammatory chemicals called leukotrienes may raise risk and could influence how much benefit someone gets from leukotriene‑blocking medicines like montelukast or zileuton. Not every difference in response is genetic, but other factors like age, nasal polyps, and coexisting asthma control also matter. Right now, there isn’t a validated pharmacogenetic test used in routine care to pick or dose medicines for this condition; doctors mainly rely on your history, aspirin challenge or desensitization, and how you respond over time. As research grows, genetic clues may help tailor decisions such as who is most likely to benefit from leukotriene modifiers or high‑dose aspirin after desensitization, and who might do better with a biologic.
Interactions with other conditions
Aspirin‑induced respiratory disease often travels alongside asthma and chronic sinus disease with nasal polyps, so flares in one can quickly ripple into the others. Someone might notice their symptoms flare when another condition is active. Early symptoms of Aspirin‑induced respiratory disease can resemble seasonal allergies, and when hay fever or a head cold kicks up, congestion, loss of smell, and wheeze may intensify. Reflux, sleep apnea, and recurrent sinus infections can also aggravate breathing and make asthma control harder in people with Aspirin‑induced respiratory disease. Heart and blood vessel conditions add another layer, because standard low‑dose aspirin after a heart attack or stent may trigger respiratory reactions; in these cases, coordinated care and, when appropriate, aspirin desensitization can allow needed cardiac treatment. Biologic medicines used for severe asthma or nasal polyps sometimes help across these overlapping problems, easing symptoms in both the chest and sinuses.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns: someone with long-standing nasal congestion and asthma would feel suddenly worse after taking a common pain reliever. A cold drink at a football match, a headache after a long day—one aspirin tablet, then wheezing, chest tightness, and a blocked nose that seemed to swell shut. Over time, people living with these reactions also developed stubborn sinus trouble and nasal polyps that came back even after surgery.
First described in the medical literature as a triad of asthma, nasal polyps, and reactions to aspirin, this is now known as aspirin‑induced respiratory disease. Early doctors recognized the link mainly through bedside observation. They saw that symptoms often began in young to middle adulthood and that similar reactions could occur with other nonsteroidal anti‑inflammatory drugs (NSAIDs). As medical science evolved, researchers began to profile the airway inflammation more precisely and noticed that standard allergy tests were often negative, suggesting a different pathway than classic allergies.
In recent decades, awareness has grown that aspirin‑induced respiratory disease is not rare among adults with difficult‑to‑control asthma or recurrent nasal polyps. Clinics started tracking who reacted to which medicines, and challenge tests under medical supervision confirmed patterns seen in everyday life. Scientists also mapped out chemical signals in the airways, especially those related to leukotrienes—molecules that can tighten breathing tubes and swell nasal tissue—helping explain why some medicines trigger symptoms while others do not.
From early theories to modern research, the story of aspirin‑induced respiratory disease has broadened to include varied paths to care. Some found relief by strictly avoiding certain pain relievers. Others benefitted from aspirin desensitization—carefully introducing small, then gradually larger doses under close monitoring—to reduce reactions and help with nasal symptoms. Surgical advances for polyps and newer medicines that target specific inflammation patterns added further options.
Understandings have changed, but the lived experience remains central: a predictable flare after a common painkiller, persistent sinus pressure, reduced sense of smell, and asthma that feels harder to steady. Today, the history of careful observation—at home, in clinics, and in research centers—continues to shape care, guiding safer pain‑relief choices and more personalized treatment plans for people with aspirin‑induced respiratory disease.